{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:47:16Z","timestamp":1789480036073,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200386"],"award-info":[{"award-number":["82200386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese\u00a0Postdoctoral Science\u00a0Foundation, China","award":["2022M712590"],"award-info":[{"award-number":["2022M712590"]}]},{"name":"The Science and Technology Research and Development Program of Shaanxi Province, China","award":["2022JQ-881"],"award-info":[{"award-number":["2022JQ-881"]}]},{"name":"Basic Research Program Youth Project of Shanxi Province, China","award":["202203021222371"],"award-info":[{"award-number":["202203021222371"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15230-5","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:59:35Z","timestamp":1765803575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineered hUCMSC-derived extracellular vesicles deliver circ-0000258 to restore p53-mediated tumor suppression in papillary thyroid carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Chan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"6","key":"15230_CR1","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.radcr.2025.02.075","volume":"20","author":"Y Xie","year":"2025","unstructured":"Xie Y, Zhang Y, Chen Z, Wei A. Sonographic manifestations of multiple medullary carcinoma coexisting with papillary carcinoma of the thyroid: a case report. Radiol Case Rep. 2025;20(6):2895\u20138.","journal-title":"Radiol Case Rep"},{"issue":"3","key":"15230_CR2","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.21037\/tcr-24-1038","volume":"14","author":"Y Su","year":"2025","unstructured":"Su Y, Jin Y. A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors. Transl Cancer Res. 2025;14(3):2125\u201349.","journal-title":"Transl Cancer Res"},{"key":"15230_CR3","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2025.50.63.45996","volume":"50","author":"S Kalode","year":"2025","unstructured":"Kalode S, Ghewade P, Tekulwar P. Papillary thyroid carcinoma: an interesting case report. Pan Afr Med J. 2025;50:9.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"15230_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-023-00629-9","volume":"23","author":"H Xu","year":"2023","unstructured":"Xu H, Wu W, Zhao Y, Liu Z, Bao D, Li L, et al. Analysis of preoperative computed tomography radiomics and clinical factors for predicting postsurgical recurrence of papillary thyroid carcinoma. Cancer Imaging. 2023;23(1):118.","journal-title":"Cancer Imaging"},{"issue":"10","key":"15230_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/cancers11101516","volume":"11","author":"M Appetecchia","year":"2019","unstructured":"Appetecchia M, Lauretta R, Barnabei A, Pieruzzi L, Terrenato I, Cavedon E, et al. Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC\/PTC): an Italian multicenter study. Cancers (Basel). 2019;11(10):1516.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"15230_CR6","first-page":"90","volume":"43","author":"S Pourseirafi","year":"2018","unstructured":"Pourseirafi S, Shishehgar M, Ashraf MJ, Faramarzi M. Papillary carcinoma of thyroid with nasal cavity metastases: a case report. Iran J Med Sci. 2018;43(1):90\u20133.","journal-title":"Iran J Med Sci"},{"issue":"49","key":"15230_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009078","volume":"96","author":"C Cheng","year":"2017","unstructured":"Cheng C, Zhou J, Shao X. Lung adenocarcinoma and pulmonary metastases coexist in a patient with papillary thyroid carcinoma: a case report. Medicine. 2017;96(49):e9078.","journal-title":"Medicine"},{"issue":"4","key":"15230_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.32604\/or.2022.025323","volume":"29","author":"ZN Navaei","year":"2021","unstructured":"Navaei ZN, Khalili-Tanha G, Zangouei AS, Abbaszadegan MR, Moghbeli M. PI3K\/AKT signaling pathway as a critical regulator of cisplatin response in tumor cells. Oncol Res. 2021;29(4):235\u201350.","journal-title":"Oncol Res"},{"issue":"2","key":"15230_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41417-023-00702-2","volume":"31","author":"W Wang","year":"2024","unstructured":"Wang W, Ding Y, Zhao Y, Li X. M6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma. Cancer Gene Ther. 2024;31(2):285\u201399.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"15230_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/oncolo\/oyad310","volume":"29","author":"MM Germani","year":"2024","unstructured":"Germani MM, Boccaccio C, Matrone A, Molinaro E, Ali G, Giordano M, et al. A misleading case of NTRK-rearranged papillary thyroid carcinoma. Oncologist. 2024;29(1):84\u20138.","journal-title":"Oncologist"},{"issue":"18","key":"15230_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810378","volume":"23","author":"SM Kim","year":"2022","unstructured":"Kim SM, Park K, Lim JH, Yun HJ, Kim SY, Choi KH, et al. Potential therapeutic agents against Paclitaxel-and Sorafenib-resistant papillary thyroid carcinoma. Int J Mol Sci. 2022;23(18):10378.","journal-title":"Int J Mol Sci"},{"key":"15230_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1807386","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Li Z. TREM2 is a prognostic biomarker and correlated with an immunosuppressive microenvironment in thyroid cancer. Dis Markers. 2022;2022:1807386.","journal-title":"Dis Markers"},{"issue":"4","key":"15230_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular rnas in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319\u201336.","journal-title":"Trends Cancer"},{"issue":"8","key":"15230_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15230_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.925389","volume":"9","author":"X Yao","year":"2022","unstructured":"Yao X, Zhang Q. Function and clinical significance of circular RNAs in thyroid cancer. Front Mol Biosci. 2022;9:925389.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"15230_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052\u201366.","journal-title":"J Clin Invest"},{"issue":"6","key":"15230_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1080\/15548627.2024.2312790","volume":"20","author":"S Diaz-Gago","year":"2024","unstructured":"Diaz-Gago S, Vicente-Gutierrez J, Ruiz-Rodriguez JM, Calafell J, Alvarez-Alvarez A, Lasa M, et al. Autophagy sustains mitochondrial respiration and determines resistance to BRAF(V600E) inhibition in thyroid carcinoma cells. Autophagy. 2024;20(6):1383\u201397.","journal-title":"Autophagy"},{"key":"15230_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.placenta.2024.09.018","volume":"158","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Ross K, Sekar D. The emerging role of microrna-based therapeutics in the treatment of preeclampsia. Placenta. 2024;158:38\u201347.","journal-title":"Placenta"},{"key":"15230_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.106106","volume":"134","author":"D Sekar","year":"2022","unstructured":"Sekar D, Selvakumar SC, Auxzilia Preethi K. Therapeutic nature of MicroRNAs in oral squamous cell carcinoma (OSCC). Oral Oncol. 2022;134:106106.","journal-title":"Oral Oncol"},{"issue":"1","key":"15230_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-024-00528-2","volume":"26","author":"C Li","year":"2025","unstructured":"Li C, Zhao X, Zhao J, Zhao J, An L, Wu G. BRAF regulates circPSD3\/miR-526b\/RAP2A axis to hinder papillary thyroid carcinoma progression. BMC Mol Cell Biol. 2025;26(1):6.","journal-title":"BMC Mol Cell Biol"},{"issue":"5","key":"15230_CR21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.7150\/thno.39238","volume":"10","author":"Y Hu","year":"2020","unstructured":"Hu Y, Zhang Y, Ni CY, Chen CY, Rao SS, Yin H, et al. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. Theranostics. 2020;10(5):2293\u2013308.","journal-title":"Theranostics"},{"key":"15230_CR22","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.2147\/IJN.S476151","volume":"19","author":"X Luo","year":"2024","unstructured":"Luo X, Wang Y, Mao Y, Xu X, Gu W, Li W, et al. Nebulization of hypoxic hUCMSC-EVs attenuates airway epithelial barrier defects in chronic asthma mice by transferring CAV-1. Int J Nanomed. 2024;19:10941\u201359.","journal-title":"Int J Nanomed"},{"key":"15230_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jad.2020.10.044","volume":"279","author":"A Gori","year":"2021","unstructured":"Gori A, Topino E, Sette A, Cramer H. Pathways to post-traumatic growth in cancer patients: moderated mediation and single mediation analyses with resilience, personality, and coping strategies. J Affect Disord. 2021;279:692\u2013700.","journal-title":"J Affect Disord"},{"issue":"1","key":"15230_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, Peng ZY, Wang R, Li X, Du N, Liu DP, et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 2023;22(1):103.","journal-title":"Mol Cancer"},{"issue":"1","key":"15230_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01529-5","volume":"21","author":"W Liu","year":"2022","unstructured":"Liu W, Zheng L, Zhang R, Hou P, Wang J, Wu L, et al. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma. Mol Cancer. 2022;21(1):72.","journal-title":"Mol Cancer"},{"key":"15230_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3977189","volume":"2021","author":"YM Jiang","year":"2021","unstructured":"Jiang YM, Liu W, Jiang L, Chang H. Circldlr promotes papillary thyroid carcinoma tumorigenicity by regulating miR-637\/LMO4 axis. Dis Markers. 2021;2021:3977189.","journal-title":"Dis Markers"},{"issue":"18","key":"15230_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-3650","volume":"10","author":"X Liu","year":"2022","unstructured":"Liu X, Wang C, Su Z, Cai S, Pan Q, Chen X. Circ_0001658 regulates PI3K\/AKT signaling via the miR-671-5p\/ITGA2 axis and affects the progress of papillary thyroid carcinoma. Ann Transl Med. 2022;10(18):1001.","journal-title":"Ann Transl Med"},{"issue":"4","key":"15230_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283589","volume":"18","author":"H Ayaz","year":"2023","unstructured":"Ayaz H, Aslam N, Awan FM, Basri R, Rauff B, Alzahrani B, et al. Mapping circRNA-miRNA-mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection. PLoS ONE. 2023;18(4):e0283589.","journal-title":"PLoS ONE"},{"issue":"3","key":"15230_CR29","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/07391102.2023.2291834","volume":"43","author":"TC Dakal","year":"2025","unstructured":"Dakal TC, Kumar A, Maurya PK. CircRNA-miRNA-mRNA interactome analysis in endometrial cancer. J Biomol Struct Dyn. 2025;43(3):1486\u201397.","journal-title":"J Biomol Struct Dyn"},{"issue":"21","key":"15230_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12212578","volume":"12","author":"A Made","year":"2023","unstructured":"Made A, Bibi A, Garcia-Manteiga JM, Tascini AS, Piella SN, Tikhomirov R, et al. Circrna-mirna-mrna deregulated network in ischemic heart failure patients. Cells. 2023;12(21):2578.","journal-title":"Cells"},{"issue":"8","key":"15230_CR31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1158\/0008-5472.CAN-14-2108","volume":"75","author":"R Liu","year":"2015","unstructured":"Liu R, Liu C, Chen D, Yang WH, Liu X, Liu CG, et al. FOXP3 controls an miR-146\/NF-kappaB negative feedback loop that inhibits apoptosis in breast cancer cells. Cancer Res. 2015;75(8):1703\u201313.","journal-title":"Cancer Res"},{"issue":"1","key":"15230_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02366-w","volume":"24","author":"H Abolfathi","year":"2023","unstructured":"Abolfathi H, Arabi M, Sheikhpour M. A literature review of MicroRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer. Respir Res. 2023;24(1):55.","journal-title":"Respir Res"},{"key":"15230_CR33","doi-asserted-by":"publisher","unstructured":"Saha A, Raja T, Dutt Dwary A, Ghosh I, Narayan Mahapatra P, Mukhopadhay T. BRAF inhibitors with or without MEK inhibitors in advanced BRAF-positive non-small cell lung cancer: a systematic review. J Oncol Pharm Pract. 2025;31(6):991\u20139. https:\/\/doi.org\/10.1177\/10781552251322452.","DOI":"10.1177\/10781552251322452"},{"issue":"1","key":"15230_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-025-00223-0","volume":"18","author":"D Sun","year":"2025","unstructured":"Sun D, Zhang X, Jin X, Shi C, Sun Y, Zhang Y, et al. BRAF(V600E) mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials. Thyroid Res. 2025;18(1):5.","journal-title":"Thyroid Res"},{"key":"15230_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113617","volume":"381","author":"Y Alshehry","year":"2025","unstructured":"Alshehry Y, Liu X, Zhang Y, Zhu G. Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine. J Control Release. 2025;381:113617.","journal-title":"J Control Release"},{"issue":"9","key":"15230_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn7256","volume":"11","author":"K Yang","year":"2025","unstructured":"Yang K, Bai B, Li X, Rou W, Huang C, Lu M, et al. Coordinating interleukin-2 encoding circrna with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy. Sci Adv. 2025;11(9):eadn7256.","journal-title":"Sci Adv"},{"key":"15230_CR37","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2410.10022","volume":"35","author":"H Kim","year":"2024","unstructured":"Kim H, Shin HY, Park M, Ahn K, Kim SJ, An SH. Exosome-like vesicles from lithospermum erythrorhizon callus enhanced wound healing by reducing LPS-induced inflammation. J Microbiol Biotechnol. 2024;35:e2410022.","journal-title":"J Microbiol Biotechnol"},{"issue":"17","key":"15230_CR38","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/eurheartj\/ehae883","volume":"46","author":"Y You","year":"2025","unstructured":"You Y, Tian Y, Guo R, Shi J, Kwak KJ, Tong Y, et al. Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. Eur Heart J. 2025;46(17):1662\u201376.","journal-title":"Eur Heart J"},{"issue":"5","key":"15230_CR39","first-page":"594","volume":"26","author":"Z Nasrpour Navaei","year":"2023","unstructured":"Nasrpour Navaei Z, Taghehchian N, Zangouei AS, Abbaszadegan MR, Moghbeli M. Microrna-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways. Iran J Basic Med Sci. 2023;26(5):594\u2013602.","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"15230_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11010-020-03960-y","volume":"476","author":"D Sekar","year":"2021","unstructured":"Sekar D. Implications of microrna 21 and its involvement in the treatment of different type of arthritis. Mol Cell Biochem. 2021;476(2):941\u20137.","journal-title":"Mol Cell Biochem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15230-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:59:37Z","timestamp":1765803577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15230-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15230"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15230-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thirty pairs of tumor tissue and paired adjacent cancerous tissues were obtained from patients diagnosed with PTC at the First Hospital of Shanxi Medical University. All patients participating in the study were aware of the research content, purpose, risks, benefits and signed the informed consent form. The research content of this article had been approved by the First Hospital of Shanxi Medical University Animal Ethics Committee. All experiments were performed in accordance with relevant guidelines and regulations. The research carried out on humans and\/or human data was in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1868"}}